Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FY8ME
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,319
Award facts
- Contract value 100% obligated
- $6,318.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,318.60 delivery order to AmerisourceBergen Drug Corp for the supply of HEPLISAV-B 20 mcg/0.5 ml syringes on July 29, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by July 30, 2025, with performance executed from the contractor's location in Conshohocken, Pennsylvania. HEPLISAV-B is a recombinant hepatitis B vaccine indicated for prevention of hepatitis B virus infection in adults. This delivery order represents a tactical procurement fulfilling immediate federal medical supply needs within the military healthcare system.
This award constitutes a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical products, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems. The competitively awarded delivery order demonstrates the contractor's capability to meet urgent federal procurement requirements and reflects DLA's ongoing pharmaceutical supply chain management for the Defense Health Agency and related government healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FY8ME?
SPE2DB25FY8ME was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FY8ME worth?
The government has obligated $6,319 on SPE2DB25FY8ME.
Is contract SPE2DB25FY8ME an order under another contract?
Yes. SPE2DB25FY8ME is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8ME competed?
The extent of competition for SPE2DB25FY8ME was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award